Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rezatomidine for Fibromyalgia Pain
NCT00445705Phase 2Terminated
- Sponsor
- Allergan
- Start
- Mar 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of rezatomidine in fibromyalgia (FM), sponsored by Allergan. Started Mar 2007; status: terminated.
02
Drugs
rezatomidine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00445705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445705.